Sealing Moderate Coronary Saphenous VEin Graft LEsions With the Paclitaxel-Eluting Stent (Taxus) as a New Approach to Maintain Vein Graft Patency and Reduce Cardiac Events: a Pilot Intravascular Ultrasound Study.

Trial Profile

Sealing Moderate Coronary Saphenous VEin Graft LEsions With the Paclitaxel-Eluting Stent (Taxus) as a New Approach to Maintain Vein Graft Patency and Reduce Cardiac Events: a Pilot Intravascular Ultrasound Study.

Completed
Phase of Trial: Phase IV

Latest Information Update: 01 Jan 2014

At a glance

  • Drugs Paclitaxel (Primary)
  • Indications Coronary artery disease; Coronary artery restenosis
  • Focus Therapeutic Use
  • Acronyms VELETI
  • Most Recent Events

    • 14 Mar 2010 Results were presented at the 59th Annual Scientific Session of the American College of Cardiology.
    • 09 Jan 2009 Actual end date changed from May 2008 to Oct 2008 as reported by Clinicaltrials.gov.
    • 09 Jan 2009 Actual patient number changed from 69 to 57 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top